Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Recurrent Glioblastoma
Related studies linked through entity extraction aliases.
Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
- Status
- UNKNOWN
- Phase
- PHASE1
Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Reirradiation and Niraparib in Patients With Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CARv3-TEAM-E T Cells in Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1
RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Surgical Pembro +/- Olaparib w TMZ for rGBM
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Trial for Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- NA
Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Status
- RECRUITING
- Phase
- PHASE1
PARP Inhibition for Gliomas (PI-4G or π4g)
- Status
- TERMINATED
- Phase
- PHASE2